Anti-Human IGF1 and IGF2 Therapeutic Antibody (Xentuzumab)

Recombinant monoclonal antibody to IGF1 and IGF2. xentuzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Solid tumors. It neutralises IGF-1 and IGF-2 function.
Supplier Creative Biolabs
Product # TAB-475CQ
Pricing Inquiry
Host Human
Target IGF1 and IGF2
Species Reactivity Human
Type IgG1, λ1
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Neutralization
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback